AU781842B2 - Use of growth hormone (hGH) for the treatment of sexual functional disturbances - Google Patents

Use of growth hormone (hGH) for the treatment of sexual functional disturbances Download PDF

Info

Publication number
AU781842B2
AU781842B2 AU62635/00A AU6263500A AU781842B2 AU 781842 B2 AU781842 B2 AU 781842B2 AU 62635/00 A AU62635/00 A AU 62635/00A AU 6263500 A AU6263500 A AU 6263500A AU 781842 B2 AU781842 B2 AU 781842B2
Authority
AU
Australia
Prior art keywords
substances
hgh
growth hormone
sexual
stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62635/00A
Other languages
English (en)
Other versions
AU6263500A (en
Inventor
Armin Johannes Becker
Udo Jonas
Christian Georg Stief
Stefan Uckert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6263500A publication Critical patent/AU6263500A/en
Application granted granted Critical
Publication of AU781842B2 publication Critical patent/AU781842B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
AU62635/00A 1999-06-17 2000-06-15 Use of growth hormone (hGH) for the treatment of sexual functional disturbances Ceased AU781842B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19927678 1999-06-17
DE19927678 1999-06-17
PCT/EP2000/005517 WO2000078328A2 (de) 1999-06-17 2000-06-15 VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN

Publications (2)

Publication Number Publication Date
AU6263500A AU6263500A (en) 2001-01-09
AU781842B2 true AU781842B2 (en) 2005-06-16

Family

ID=7911578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62635/00A Ceased AU781842B2 (en) 1999-06-17 2000-06-15 Use of growth hormone (hGH) for the treatment of sexual functional disturbances

Country Status (6)

Country Link
EP (1) EP1207902A2 (zh)
JP (1) JP2003502379A (zh)
AU (1) AU781842B2 (zh)
CA (1) CA2377339A1 (zh)
NZ (1) NZ516223A (zh)
WO (1) WO2000078328A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120264722A1 (en) * 2004-05-11 2012-10-18 Emotional Brain B.V. Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054945B2 (en) * 2001-04-09 2006-05-30 Nokia Corporation Technique for providing announcements in mobile-originated calls
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
EP1925307A1 (en) 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
CA2643529C (en) * 2008-11-06 2019-05-21 Kenneth W. Adams Method and composition for enhancement of male erectile function

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042631A1 (en) * 1997-03-21 1998-10-01 W.R. Grace & Co.-Conn. Additive for production of highly workable mortar cement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916569A (en) * 1997-03-26 1999-06-29 E. Martin Spencer Human erectile dysfunction and methods of treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042631A1 (en) * 1997-03-21 1998-10-01 W.R. Grace & Co.-Conn. Additive for production of highly workable mortar cement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JUNG-GYUNG WOO ET AL, JOURNAL UROLOGY 1998, 160(5) 1899-1904 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120264722A1 (en) * 2004-05-11 2012-10-18 Emotional Brain B.V. Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
US9192669B2 (en) * 2004-05-11 2015-11-24 Eb Ip Lybrido B.V. Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

Also Published As

Publication number Publication date
EP1207902A2 (de) 2002-05-29
AU6263500A (en) 2001-01-09
WO2000078328A2 (de) 2000-12-28
CA2377339A1 (en) 2000-12-28
WO2000078328A3 (de) 2002-02-28
NZ516223A (en) 2003-08-29
JP2003502379A (ja) 2003-01-21

Similar Documents

Publication Publication Date Title
JP3255289B2 (ja) アルファー―２―アドレナリン作動薬及び成長ホルモン放出ペプチドによる肥満症の治療
Marshall et al. GnRH pulses--the regulators of human reproduction.
Lee et al. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling
LANCRANJAN et al. Effect of 1–5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man
MXPA05010373A (es) Inhibidores de fosfodiesterasas en infertilidad.
US6338862B1 (en) Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors
CA2230968A1 (en) Method of treating insulin resistance
Van de Waal Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin‐releasing hormone in patients with hypogonadotrophic hypogonadism
US4654324A (en) Human proinsulin pharmaceutical formulations
Kannan The pituitary gland
US4652547A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
AU781842B2 (en) Use of growth hormone (hGH) for the treatment of sexual functional disturbances
Veldhuis et al. Divergent influences of calcium ions on releasing factor-stimulated anterior pituitary hormone secretion in normal man
JP2007508381A (ja) 勃起障害治療のための方法および組成物
Kasai et al. Glycine stimulates growth hormone release in man
RU2663455C2 (ru) КОМБИНАЦИЯ АНАЛОГОВ СОМАТОСТАТИНА С ИНГИБИТОРАМИ 11β- ГИДРОКСИЛАЗЫ
EP0586812A2 (en) Medicaments comprising glicentin as active ingredient
Dimaraki et al. Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator
Lundberg Blood levels of FSH, LH, TSH, and GH in parkinsonian patients before and during L‐dopa treatment
Zgliczyński et al. The effect of D-Trp6-LRH upon secretion of gonadotrophin–a possible therapeutic application in anorexia nervosa
CN102238957A (zh) 用于增强雄性勃起功能的方法和组合物
Jauch et al. Dose-dependent effects of Human-Growth-Hormone (rHGH) on post-operative substrate metabolism
Saito et al. Effects of growth hormone dose after major abdominal operation: a randomized, prospective, multicenter trial
Milhaud et al. Response of normal, hypothyroid and hypothalamo-pituitary insufficient children to synthetic thyrotrophin-releasing hormone
Leung et al. Neuroendocrine complications of cancer therapy